The Global Health Group is an “action tank” dedicated to translating major new paradigms into large-scale action to positively impact the lives of millions of people. Led by Sir Richard Feachem, formerly founding executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, we work with researchers, policymakers and implementers to better understand and address health challenges and tackle neglected global health priorities. Through boldness, focus, collaboration and innovation, we can reduce the burden of disease and enhance economic prosperity for people around the world. Founded in 2007, GHG works closely with a wide range of public and private partners, both in-country and internationally.
We are a team of global health experts who conduct targeted research and advocacy to eliminate malaria, strengthen health systems and translate evidence to policy. We aim to expand global understanding and engage an ever-growing network of partners to take forward new approaches.
The Global Health Group also leverages our expertise and convening power to address a wider array of global health challenges, particularly around policy and financing.
Through our work, policymakers, funders and country leaders gain access to new and relevant data, recommendations and tools—and make informed decisions about the next important steps in strategy, funding and implementation. The Action Tank, illustrated below, defines this comprehensive approach.
We specialize in stimulating new ways of thinking and expanding the marketplace of ideas by identifying opportunities for impact where new paradigms offer solutions to old problems, or by taking a new view that can help to move innovative research to policy.
- Malaria Elimination Initiative develops innovative, strategic, and evidence-based solutions for countries and regions to eliminate malaria.
- Pandemic Response Initiative to help Low- and middle-income countries develop their own playbooks to prevent widespread devastation from the COVID-19 pandemic, tailored to the realities of their populations and economies.
- Evidence to Policy Initiative conducts policy analyses, research, and agenda-setting activities to help policymakers from donor agencies and low- and middle-income countries create and implement high-impact, evidence-based policies to improve the health of people around the world.
Leadership and Administration
- Sir Richard Feachem, DSc (Med), PhD, Director
- Jeremy Alberga, MA, Chief Operating Officer
- Hyunju Woo
- Advisory Board
Malaria Elimination Initiative
- Roly Gosling, MD, PhD, Lead
- Kimberly Baltzell, PhD, MS
- Adam Bennett, MA, PhD
- Anne Bulchis
- Ingrid Chen, MS, PhD
- Chris Cotter, MPH
- Tiese Etim-Inyang
- Bryan Greenhouse
- Michelle Hsiang, MD
- Saehee Lee
- Neil Lobo
- Gretchen Newby, MPH
- Laura Newman
- Henry Ntuku
- Francois Rerolle
- Michelle Roh, MPH
- Valerie Scott
- Cara Smith Gueye, MPH
- Jenny Smith, PhD
- Allison Tatarksy, MA
- Elodie Vajda
- Jeny Wegbreit
- Chris White
Pandemic Response Initiative
- Kelly Sanders, MD, MS
- ACCESS Health International
- Australia Department of Foreign Affairs and Trade
- Bill & Melinda Gates Foundation
- Center for Disease Dynamics, Economics & Policy
- Center for Policy Impact in Global Health at Duke University
- Elimination 8 (E8)
- DCP3 (Disease Control Priorities)
- DKT International
- Glaser Progress Foundation
- Global Fund
- Malaria Atlas Project
- Malaria Elimination Group
- Malaria Eradication Scientific Alliance
- Malaria No More
- Ministry of Health and Social Services of Namibia
- National Malaria Control Program of Swaziland
- Parker Foundation
- Philip R. Lee Institute for Health Policy Studies
- Price Waterhouse Coopers
- Results for Development
- SEEK Development
- Society for Family Health
- Stanford Center for Innovation in Global Health
- Foreign, Commonwealth & Development Office
- University Cheikh Anta DIOP of Dakar Senegal
- University of Queensland
- William & Flora Hewlett Foundation